Advertisement
EVC vs HHS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVC is a Buy and HHS is a Hold.
EVC in upward trend: price rose above 50-day moving average on November 04, 2026
EVC moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 39 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on EVC as a result. In 65 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for EVC just turned positive on October 21, 2026. Looking at past instances where EVC's MACD turned positive, the stock continued to rise in 33 of 42 cases over the following month. The odds of a continued upward trend are 79%.
The 10-day moving average for EVC crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.
Following a +24.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVC advanced for three days, in 180 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
EVC broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EVC entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. EVC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.929) is normal, around the industry mean (-1.802). EVC's P/E Ratio (224.750) is considerably higher than the industry average of (21.593). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (1.501). Dividend Yield (0.022) settles around the average of (0.084) among similar stocks. P/S Ratio (1.107) is also within normal values, averaging (1.860).
HHS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for HHS turned positive on November 09, 2026. Looking at past instances where HHS's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HHS's RSI Indicator exited the oversold zone, 18 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
Following a +2.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HHS advanced for three days, in 181 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
HHS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 52 cases where HHS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HHS as a result. In 75 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
HHS moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HHS crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for HHS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.923) is normal, around the industry mean (-1.578). P/E Ratio (-5.143) is within average values for comparable stocks, (18.965). Projected Growth (PEG Ratio) (0.472) is also within normal values, averaging (0.772). Dividend Yield (0.859) settles around the average of (674.816) among similar stocks. P/S Ratio (0.219) is also within normal values, averaging (2.059).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. HHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
EVC | HHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 68 | 100 | |
SMR RATING 1..100 | 83 | 97 | |
PRICE GROWTH RATING 1..100 | 35 | 37 | |
P/E GROWTH RATING 1..100 | 70 | 94 | |
SEASONALITY SCORE 1..100 | 37 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HHS's Valuation (35) in the Advertising Or Marketing Services industry is somewhat better than the same rating for EVC (86) in the Broadcasting industry. This means that HHS’s stock grew somewhat faster than EVC’s over the last 12 months.
EVC's Profit vs Risk Rating (68) in the Broadcasting industry is in the same range as HHS (100) in the Advertising Or Marketing Services industry. This means that EVC’s stock grew similarly to HHS’s over the last 12 months.
EVC's SMR Rating (83) in the Broadcasting industry is in the same range as HHS (97) in the Advertising Or Marketing Services industry. This means that EVC’s stock grew similarly to HHS’s over the last 12 months.
EVC's Price Growth Rating (35) in the Broadcasting industry is in the same range as HHS (37) in the Advertising Or Marketing Services industry. This means that EVC’s stock grew similarly to HHS’s over the last 12 months.
EVC's P/E Growth Rating (70) in the Broadcasting industry is in the same range as HHS (94) in the Advertising Or Marketing Services industry. This means that EVC’s stock grew similarly to HHS’s over the last 12 months.
| EVC | HHS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 71% | 2 days ago 62% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 73% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 83% |
| Advances ODDS (%) | 3 days ago 74% | 9 days ago 72% |
| Declines ODDS (%) | 17 days ago 75% | 21 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVC’s FA Score shows that 0 FA rating(s) are green while HHS’s FA Score has 0 green FA rating(s).
- EVC’s FA Score: 0 green, 5 red.
- HHS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVC’s TA Score shows that 5 TA indicator(s) are bullish while HHS’s TA Score has 4 bullish TA indicator(s).
- EVC’s TA Score: 5 bullish, 5 bearish.
- HHS’s TA Score: 4 bullish, 6 bearish.
Price Growth
EVC (@Advertising/Marketing Services) experienced а +31.65% price change this week, while HHS (@Industrial Conglomerates) price change was -0.50% for the same time period.
The average weekly price growth across all stocks in the @Advertising/Marketing Services industry was +3.81%. For the same industry, the average monthly price growth was +3.70%, and the average quarterly price growth was +2.46%.
The average weekly price growth across all stocks in the @Industrial Conglomerates industry was +2.62%. For the same industry, the average monthly price growth was -0.36%, and the average quarterly price growth was -7.01%.
Industries' Descriptions
@Advertising/Marketing Services (+3.81% weekly)Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.
@Industrial Conglomerates (+2.62% weekly)Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).
Advertisement
EVC and
Correlation & Price change
A.I.dvisor tells us that EVC and MCHX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVC and MCHX's prices will move in lockstep.
| Ticker / NAME | Correlation To EVC | 1D Price Change % | ||
|---|---|---|---|---|
| EVC | 100% | -2.04% | ||
| MCHX - EVC | 33% Poorly correlated | +5.26% | ||
| BOC - EVC | 31% Poorly correlated | -0.58% | ||
| STFS - EVC | 31% Poorly correlated | -5.84% | ||
| DLX - EVC | 28% Poorly correlated | +2.55% | ||
| HHS - EVC | 24% Poorly correlated | -1.00% | ||
More | ||||
HHS and
Correlation & Price change
A.I.dvisor tells us that HHS and WPP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HHS and WPP's prices will move in lockstep.